
In an exciting collaboration, Iktos, a leading artificial intelligence (AI) drug discovery company, has partnered with Kissei, a prominent Japanese pharmaceutical company, to introduce Makya™, an AI-driven drug discovery platform. This innovative partnership aims to revolutionize the process of designing new small molecules by leveraging the power of AI technology. Makya™ is set to redefine the field of drug discovery